Platform Technology Partners Purchases 178 Shares of Zoetis Inc. (NYSE:ZTS)

Platform Technology Partners lifted its position in Zoetis Inc. (NYSE:ZTS) by 8.1% during the 4th quarter, HoldingsChannel reports. The firm owned 2,363 shares of the company’s stock after buying an additional 178 shares during the period. Platform Technology Partners’ holdings in Zoetis were worth $385,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Darwin Wealth Management LLC bought a new position in Zoetis in the 3rd quarter worth about $31,000. First Personal Financial Services bought a new position in shares of Zoetis in the third quarter worth approximately $33,000. Capital Performance Advisors LLP purchased a new stake in Zoetis in the third quarter valued at approximately $33,000. Dunhill Financial LLC raised its stake in Zoetis by 80.6% in the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock valued at $33,000 after purchasing an additional 75 shares in the last quarter. Finally, Fortitude Family Office LLC lifted its position in Zoetis by 1,387.5% during the third quarter. Fortitude Family Office LLC now owns 238 shares of the company’s stock valued at $46,000 after purchasing an additional 222 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Zoetis Trading Down 1.6 %

NYSE:ZTS opened at $171.37 on Friday. The company has a fifty day moving average of $169.34 and a 200 day moving average of $179.28. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The firm has a market capitalization of $77.32 billion, a P/E ratio of 32.21, a P/E/G ratio of 2.77 and a beta of 0.90. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 3rd. Shareholders of record on Monday, April 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.17%. The ex-dividend date of this dividend is Monday, April 21st. Zoetis’s payout ratio is 37.59%.

Analyst Ratings Changes

ZTS has been the topic of a number of research analyst reports. JPMorgan Chase & Co. increased their price target on shares of Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Morgan Stanley lowered their price target on Zoetis from $248.00 to $243.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 29th. Leerink Partners assumed coverage on Zoetis in a report on Monday, December 2nd. They issued an “outperform” rating and a $215.00 price objective for the company. UBS Group began coverage on Zoetis in a report on Monday, December 9th. They set a “neutral” rating and a $196.00 price objective on the stock. Finally, Leerink Partnrs raised Zoetis to a “strong-buy” rating in a research note on Monday, December 2nd. One analyst has rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average price target of $215.00.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.